These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

211 related items for PubMed ID: 26468002

  • 1. Prevalence and determinants of unintended double medication of antihypertensive, lipid-lowering, and hypoglycemic drugs in Austria: a nationwide cohort study.
    Heinze G, Jandeck LM, Hronsky M, Reichardt B, Baumgärtel C, Bucsics A, Müllner M, Winkelmayer WC.
    Pharmacoepidemiol Drug Saf; 2016 Jan; 25(1):90-9. PubMed ID: 26468002
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Impact of Medicaid prescription copayments on use of antipsychotics and other medications in patients with schizophrenia.
    Doshi JA, Li P, Desai S, Marcus SC.
    J Med Econ; 2017 Dec; 20(12):1252-1260. PubMed ID: 28792299
    [Abstract] [Full Text] [Related]

  • 4. Effect of the Medicare Part D coverage gap on medication use among patients with hypertension and hyperlipidemia.
    Li P, McElligott S, Bergquist H, Schwartz JS, Doshi JA.
    Ann Intern Med; 2012 Jun 05; 156(11):776-84, W-263, W-264, W-265, W-266, W-267, W-268, W-269. PubMed ID: 22665815
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of drug usage and expenditure in a hospital diabetes clinic.
    Wu SY, Lung BC, Chang S, Lee SC, Critchley JA, Chan JC.
    J Clin Pharm Ther; 1998 Feb 05; 23(1):49-56. PubMed ID: 9756112
    [Abstract] [Full Text] [Related]

  • 6. Antihypertensive, antidiabetic and lipid-lowering treatment frequencies in France in 2010.
    Tuppin P, Ricci-Renaud P, de Peretti C, Fagot-Campagna A, Gastaldi-Menager C, Danchin N, Alla F, Allemand H.
    Arch Cardiovasc Dis; 2013 May 05; 106(5):274-86. PubMed ID: 23769402
    [Abstract] [Full Text] [Related]

  • 7. Drug therapy of cardiovascular risk factors: guidelines versus reality in primary health care service.
    Marković BB, Kranjcević K, Reiner Z, Blazeković SM, Spehar SS.
    Croat Med J; 2005 Dec 05; 46(6):984-9. PubMed ID: 16342354
    [Abstract] [Full Text] [Related]

  • 8. Comparative effectiveness of branded vs. generic versions of antihypertensive, lipid-lowering and hypoglycemic substances: a population-wide cohort study.
    Tian Y, Reichardt B, Dunkler D, Hronsky M, Winkelmayer WC, Bucsics A, Strohmaier S, Heinze G.
    Sci Rep; 2020 Apr 06; 10(1):5964. PubMed ID: 32249786
    [Abstract] [Full Text] [Related]

  • 9. Association between prescription burden and medication adherence in patients initiating antihypertensive and lipid-lowering therapy.
    Benner JS, Chapman RH, Petrilla AA, Tang SS, Rosenberg N, Schwartz JS.
    Am J Health Syst Pharm; 2009 Aug 15; 66(16):1471-7. PubMed ID: 19667004
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Is global cardiovascular risk considered in current practice? Treatment and control of hypertension, hyperlipidemia, and diabetes according to patients' risk level.
    Roccatagliata D, Avanzini F, Monesi L, Caimi V, Lauri D, Longoni P, Marchioli R, Tombesi M, Tognoni G, Roncaglioni MC, Collaborative Group Risk and Prevention Study.
    Vasc Health Risk Manag; 2006 Aug 15; 2(4):507-14. PubMed ID: 17323606
    [Abstract] [Full Text] [Related]

  • 15. Incidence of cardiovascular events in Italian patients with early discontinuations of antihypertensive, lipid-lowering, and antidiabetic treatments.
    Corrao G, Zambon A, Parodi A, Merlino L, Mancia G.
    Am J Hypertens; 2012 May 15; 25(5):549-55. PubMed ID: 22278212
    [Abstract] [Full Text] [Related]

  • 16. Medication regimen complexity in patients with uncontrolled hypertension and/or diabetes.
    Rettig SM, Wood Y, Hirsch JD.
    J Am Pharm Assoc (2003); 2013 May 15; 53(4):427-31. PubMed ID: 23892818
    [Abstract] [Full Text] [Related]

  • 17. Impact of a value-based formulary in three chronic disease cohorts.
    Yeung K, Basu A, Marcum ZA, Watkins JB, Sullivan SD.
    Am J Manag Care; 2017 Mar 15; 23(3 Suppl):S46-S53. PubMed ID: 29648740
    [Abstract] [Full Text] [Related]

  • 18. Discontinuation of diabetes and lipid-lowering medications after bariatric surgery at Veterans Affairs medical centers.
    Maciejewski ML, Livingston EH, Kahwati LC, Henderson WG, Kavee AL, Arterburn DE.
    Surg Obes Relat Dis; 2010 Mar 15; 6(6):601-7. PubMed ID: 20965791
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Variation in prescription use and spending for lipid-lowering and diabetes medications in the Veterans Affairs Healthcare System.
    Gellad WF, Good CB, Lowe JC, Donohue JM.
    Am J Manag Care; 2010 Oct 15; 16(10):741-50. PubMed ID: 20964470
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.